AR038502A1 - USE OF SODIUM / HYDROGEN EXCHANGER INHIBITORS FOR THE TREATMENT OF THROMBOTIC AND INFLAMMATORY DISORDERS - Google Patents
USE OF SODIUM / HYDROGEN EXCHANGER INHIBITORS FOR THE TREATMENT OF THROMBOTIC AND INFLAMMATORY DISORDERSInfo
- Publication number
- AR038502A1 AR038502A1 ARP030100448A ARP030100448A AR038502A1 AR 038502 A1 AR038502 A1 AR 038502A1 AR P030100448 A ARP030100448 A AR P030100448A AR P030100448 A ARP030100448 A AR P030100448A AR 038502 A1 AR038502 A1 AR 038502A1
- Authority
- AR
- Argentina
- Prior art keywords
- sodium
- treatment
- thrombotic
- inhibitors
- inflammatory disorders
- Prior art date
Links
- 239000003112 inhibitor Substances 0.000 title abstract 4
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 title abstract 3
- 229910052739 hydrogen Inorganic materials 0.000 title abstract 3
- 239000001257 hydrogen Substances 0.000 title abstract 3
- 229910052708 sodium Inorganic materials 0.000 title abstract 3
- 239000011734 sodium Substances 0.000 title abstract 3
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical class [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 title abstract 2
- 208000027866 inflammatory disease Diseases 0.000 title 1
- 230000001732 thrombotic effect Effects 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 3
- 101000622137 Homo sapiens P-selectin Proteins 0.000 abstract 1
- 102100023472 P-selectin Human genes 0.000 abstract 1
- 208000007536 Thrombosis Diseases 0.000 abstract 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 1
- 230000002757 inflammatory effect Effects 0.000 abstract 1
- 230000002401 inhibitory effect Effects 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 230000028327 secretion Effects 0.000 abstract 1
- 108010047303 von Willebrand Factor Proteins 0.000 abstract 1
- 102100036537 von Willebrand factor Human genes 0.000 abstract 1
- 229960001134 von willebrand factor Drugs 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/255—Esters, e.g. nitroglycerine, selenocyanates of sulfoxy acids or sulfur analogues thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/417—Imidazole-alkylamines, e.g. histamine, phentolamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4418—Non condensed pyridines; Hydrogenated derivatives thereof having a carbocyclic group directly attached to the heterocyclic ring, e.g. cyproheptadine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/454—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Rheumatology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Pain & Pain Management (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Emergency Medicine (AREA)
- Pulmonology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Quinoline Compounds (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Pyrrole Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
- Indole Compounds (AREA)
Abstract
Inhibidores de los intercambiadores celulares de sodio/hidrógeno, ponen de manifiesto un efecto inhibidor sobre la secreción de factor de von Willebrand y/o expresión aumentada de selectina P. Estos inhibidores pueden ser empleados, por lo tanto, para el tratamiento de trastornos trombóticos e inflamatorios. Reivindicación (2): El uso según la reivindicación 1, en el que se emplea como inhibidor del intercambiador sodio/hidrógeno al menos una de los compuestos de fórmula (1) a (13): y/o una forma estereoisómera de los compuestos anteriormente citados y/o mezclas de estas formas en cualquier proporción, y/o de las sales fisiológicamente toleradas de los compuestos anteriormente citados.Inhibitors of sodium / hydrogen cell exchangers show an inhibitory effect on the secretion of von Willebrand factor and / or increased expression of selectin P. These inhibitors can therefore be used for the treatment of thrombotic disorders and inflammatory Claim (2): The use according to claim 1, wherein at least one of the compounds of formula (1) to (13) is used as an inhibitor of the sodium / hydrogen exchanger: and / or a stereoisomeric form of the compounds above cited and / or mixtures of these forms in any proportion, and / or of the physiologically tolerated salts of the aforementioned compounds.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE10206358A DE10206358A1 (en) | 2002-02-14 | 2002-02-14 | Use of inhibitors of the sodium-hydrogen exchanger for the treatment of thrombotic and inflammatory diseases |
Publications (1)
Publication Number | Publication Date |
---|---|
AR038502A1 true AR038502A1 (en) | 2005-01-19 |
Family
ID=27634998
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP030100448A AR038502A1 (en) | 2002-02-14 | 2003-02-12 | USE OF SODIUM / HYDROGEN EXCHANGER INHIBITORS FOR THE TREATMENT OF THROMBOTIC AND INFLAMMATORY DISORDERS |
Country Status (10)
Country | Link |
---|---|
EP (1) | EP1480628A1 (en) |
JP (1) | JP2005525336A (en) |
AR (1) | AR038502A1 (en) |
AU (1) | AU2003208368A1 (en) |
BR (1) | BR0307618A (en) |
CA (1) | CA2476446A1 (en) |
DE (1) | DE10206358A1 (en) |
MX (1) | MXPA04007387A (en) |
TW (1) | TW200403988A (en) |
WO (1) | WO2003068212A1 (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE10305070A1 (en) * | 2003-02-07 | 2004-08-26 | Merck Patent Gmbh | Use of sodium-hydrogen ion antiporter 1 inhibitors e.g. N-(4,5-bis-methanesulfonyl-2-methyl-2-methyl-benzoyl)-guanidine, used at doses causing only partial inhibition, e.g. for treating arrhythmia or angina |
EP2271327B1 (en) * | 2008-05-09 | 2015-05-20 | Merck Patent GmbH | Pharmaceutical composition comprising rimeporide for treating diseases associated with beta-cell dysfunction |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5627193A (en) * | 1995-02-09 | 1997-05-06 | Mitsui Toatsu Chemicals, Inc. | Quinoline-4-carbonylguanidine derivatives, process for producing the same and pharmaceutical preparations containing the compounds |
DE19734693A1 (en) * | 1997-08-11 | 1998-01-22 | Hoechst Marion Roussel De Gmbh | Use of cariporide to treat cardiac and non-cardiac disease |
-
2002
- 2002-02-14 DE DE10206358A patent/DE10206358A1/en not_active Withdrawn
-
2003
- 2003-02-03 AU AU2003208368A patent/AU2003208368A1/en not_active Abandoned
- 2003-02-03 BR BR0307618-0A patent/BR0307618A/en not_active IP Right Cessation
- 2003-02-03 WO PCT/EP2003/001020 patent/WO2003068212A1/en not_active Application Discontinuation
- 2003-02-03 MX MXPA04007387A patent/MXPA04007387A/en not_active Application Discontinuation
- 2003-02-03 CA CA002476446A patent/CA2476446A1/en not_active Abandoned
- 2003-02-03 JP JP2003567394A patent/JP2005525336A/en not_active Abandoned
- 2003-02-03 EP EP03706415A patent/EP1480628A1/en not_active Withdrawn
- 2003-02-12 TW TW092102811A patent/TW200403988A/en unknown
- 2003-02-12 AR ARP030100448A patent/AR038502A1/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
WO2003068212A1 (en) | 2003-08-21 |
TW200403988A (en) | 2004-03-16 |
EP1480628A1 (en) | 2004-12-01 |
CA2476446A1 (en) | 2003-08-21 |
MXPA04007387A (en) | 2004-10-11 |
DE10206358A1 (en) | 2003-08-28 |
BR0307618A (en) | 2004-12-21 |
AU2003208368A1 (en) | 2003-09-04 |
JP2005525336A (en) | 2005-08-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
UY38696A (en) | ALPHA-1 ANTITRYPSIN MODULATORS | |
PA8589201A1 (en) | MANDELIC ACID DERIVATIVES | |
ES2117034T3 (en) | COMPOSITION FOR GLASS CLEANING. | |
CR8193A (en) | PIPERAZINA WITH OR REPLACED FENILE GROUPS AND ITS USE AS GLYT INHIBITORS 1 | |
SE0202463D0 (en) | Novel compounds | |
ES2097872T3 (en) | PHENYLPIRAZOLIDINONES AS BRONCODILATOR AND ANTI-INFLAMMATORY AGENTS. | |
UY30314A1 (en) | BENZONITRILE DERIVATIVES REPLACED WITH GLUCOPYRANOSIL, PHARMACEUTICAL COMPOSITIONS CONTAINING COMPOUNDS OF THIS TYPE, USE AND PROCEDURE FOR MANUFACTURING | |
CL2007001391A1 (en) | Compounds derived from substituted pyrrolidines, inhibitors of factor xa and / or inhibitors on serine protease; pharmaceutical composition comprising said compounds; procedure to prepare the pharmaceutical composition; and use of the compounds to prepare a medicamneto with an antithrombotic effect | |
AR065797A1 (en) | USES AND DERIVATIVES OF 1- (2- (2,4- DIMETILFENILSULFANIL) PHENYL) PIPERAZINE | |
SE0302323D0 (en) | Novel compounds | |
UY27244A1 (en) | USE OF ACID- (4´-TRIFLUORMETHYLPHENYL) - AMIDA (Z) -2- CYANO-3- HYDROXI-BUT-2-ENOIC FOR THE TREATMENT OF MULTIPLE SCLEROSIS | |
AR059596A1 (en) | ANHYDRATE AND SOLVATED CRYSTAL FORMS OF N- (BENZO [B] TIEN-3-ILMETIL) SULFAMIDA. | |
CO2021006884A2 (en) | Ketamine Pamoate and its use | |
CO6321285A2 (en) | USE OF 3,11B-CIS- DIHIDROTETRABENAZINE IN THE TREATMENT OF MULTIPLE SCLEROSIS AND SELF-IMMUNE HONEY MIELITIS | |
PA8586801A1 (en) | HIV-INTEGRESS INHIBITORS, PHARMACEUTICAL COMPOSITIONS AND METHODS FOR USE | |
ATE331711T1 (en) | ANTI-INFLAMMATORY 3-ARYLTHIO-3-THIAZOLYLALKYLAMINE | |
UY29774A1 (en) | ATM INHIBITOR | |
CO2021006480A2 (en) | Rip1 inhibitors | |
ECSP10010159A (en) | ACID 4- [4- (2-ADAMANTILCARBAMOIL) -5-TERT-BUTILPIRAZOL-1-IL] BENZOICO - 465 | |
UY28524A1 (en) | TRIAZOL DERIVATIVES REPLACED AS AN OXITOCINE ANTAGONISTS | |
AR038502A1 (en) | USE OF SODIUM / HYDROGEN EXCHANGER INHIBITORS FOR THE TREATMENT OF THROMBOTIC AND INFLAMMATORY DISORDERS | |
PA8557201A1 (en) | BASIC LINEAR COMPOUNDS THAT HAVE NK-2 ANTAGONIST ACTIVITY AND ITS FORMULATIONS | |
SE0202461D0 (en) | Novel compounds | |
AR045392A1 (en) | COMPOSITIONS FOR HAIR TREATMENT | |
CR6797A (en) | TYPE 1 SODIUM-HYDROGEN EXCHANGER INHIBITOR (NHE-1) |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA | Abandonment or withdrawal |